Patent details

LUC00225 Product Name: ofatumumab

Basic Information

Publication number:
LUC00225
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP087813234
Legal Status:
Withdrawn
Application number:
LUC00225
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
EU/1/21/1532
Marketing Authorization Type:
Marketing Authorization Date:
29/03/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
67757 + 67758
Marketing Authorization Type:
Marketing Authorization Date:
01/02/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Switzerland (CH)

Dates

Filing date:
13/09/2021
First Marketing Authorization date:
01/02/2021
Grant date:
Activation date:
Publication date:
14/09/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
03/07/2033
SPC Extension Expiration:
03/07/2033
Rejection date:
Withdrawal date:
28/08/2024

Owner

From:
13/09/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/09/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/11
Publication date:
08/10/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
VRV
Bulletin edition number:
2024/11
Publication date:
16/09/2024
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
13/09/2021 MA publication 2
13/09/2021 Application Form 3
14/09/2021 Publication 1
13/09/2021 MA publication 9
13/09/2021 General Document 2
14/09/2021 Outgoing Correspondence 1
13/09/2021 Summary of the product caracteristics 61
13/09/2021 Marketing authorization 3
13/09/2021 Marketing authorization 10
13/09/2021 General Document 3
13/09/2021 General Document 2
28/08/2024 Incoming Correspondence (Post) 1
28/08/2024 Outgoing Correspondence 1